Changes

no edit summary
Line 2,238: Line 2,238:  
|
 
|
 
|-
 
|-
|[[HAEM5:Aggressive NK-cell leukaemia|Aggressive NK-cell leukaemia]]||Disease||PENDING
+
|[[HAEM5:Aggressive NK-cell leukaemia|Aggressive NK-cell leukaemia]]||Disease||Rabail Aslam, MD (fellow); Shashirekha Shetty, PhD
| || || || ||SK|| ||
+
|7/1/2024|| ||Pending
 +
| ||SK|| ||
 
|Aggressive NK-cell Leukemia
 
|Aggressive NK-cell Leukemia
 
|Shanelle De Lancy, MD, Shashirekha Shetty, PhD
 
|Shanelle De Lancy, MD, Shashirekha Shetty, PhD
Line 2,277: Line 2,278:  
|
 
|
 
|-
 
|-
|[[HAEM5:Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Lymphomatoid papulosis|Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Lymphomatoid papulosis]]||Disease|| || || || || ||SK|| ||
+
|[[HAEM5:Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Lymphomatoid papulosis|Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Lymphomatoid papulosis]]||Disease||Rabail Aslam, MD (fellow); Shashirekha Shetty, PhD
 +
| || ||Pending
 +
| ||SK|| ||
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
Line 2,284: Line 2,287:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
|[[HAEM5:Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Primary cutaneous anaplastic large cell lymphoma|Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Primary cutaneous anaplastic large cell lymphoma]]||Disease||PENDING
+
|[[HAEM5:Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Primary cutaneous anaplastic large cell lymphoma|Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Primary cutaneous anaplastic large cell lymphoma]]||Disease||Rabail Aslam, MD (fellow); Shashirekha Shetty, PhD
| || || || ||SK|| ||
+
| || ||Pending
 +
| ||SK|| ||
 
|Primary Cutaneous Anaplastic Large Cell Lymphoma
 
|Primary Cutaneous Anaplastic Large Cell Lymphoma
 
|Theresa Spivey, MD, Shashirekha Shetty, PhD
 
|Theresa Spivey, MD, Shashirekha Shetty, PhD